Scarica l'app Stockscreener
26.80
0.52%
-0.14
Dopo l'orario di chiusura:
26.81
0.010
+0.04%
Precedente Chiudi:
$26.94
Aprire:
$27.21
Volume 24 ore:
4,226
Relative Volume:
0.24
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+2.93%
1M Prestazione:
+6.82%
6M Prestazione:
+4.77%
1 anno Prestazione:
-10.02%
Intervallo 1D:
$26.74
$27.96
Intervallo di 1 settimana:
$26.12
$27.96
Portata 52W:
$20.10
$30.11
Tema Oncology Etf Stock (CANC) Company Profile
Nome
Tema Oncology Etf
Settore
Industria
Telefono
-
Indirizzo
-
Confronta CANC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CANC
Tema Oncology Etf
|
26.80 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
313.60 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
636.94 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
639.92 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
245.70 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
568.14 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf Borsa (CANC) Ultime notizie
How to Take Advantage of moves in (CANC) - news.stocktradersdaily.com
Summit Therapeutics Explodes 12%: Legal Probe Ignites Volatility Amid Regulatory Crosshairs - AInvest
Summit Therapeutics Soars 16.5% Amid Regulatory Crossroads and Whale Activity - AInvest
When (CANC) Moves Investors should Listen - news.stocktradersdaily.com
5 Small-cap Biotech ETFs to Watch - Investing News Network
(CANC) Investment Report - news.stocktradersdaily.com
(CANC) Technical Data - news.stocktradersdaily.com
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 - Investing News Network
Learn to Evaluate (CANC) using the Charts - news.stocktradersdaily.com
Biotech Outperformance: Can’t Take What’s Already Earned - Seeking Alpha
(CANC) Technical Pivots with Risk Controls - news.stocktradersdaily.com
(CANC) Investment Analysis and Advice - news.stocktradersdaily.com
Trend Tracker for (CANC) - Stock Traders Daily
How To Trade (CANC) - Stock Traders Daily
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Psychedelic ETF PSIL Is 2025's Best-Performing ETF - etf.com
(CANC) Long Term Investment Analysis - Stock Traders Daily
(CANC) Trading Report - Stock Traders Daily
Tema Oncology ETF (NASDAQ:CANC) Short Interest Update - Defense World
Trading (CANC) With Integrated Risk Controls - Stock Traders Daily
Tema's New VOLT ETF Sparked by AI Revolution - etf.com
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Nasdaq
Tema American Reshoring ETF: Benefiting From The Return Of U.S. Manufacturing - Seeking Alpha
Tema ETFs CIO on the Power of Biotech as a Source of Return Yuri Khodjamirian on Opportunities to Invest in Biotech - CMC Markets
9 Best Biotech ETFs for 2024 - MSN
How Big Pharma Is Taking A Page Out Of Novartis' Playbook - Investor's Business Daily
10 Best Performing Biotech ETFs in 2024 - Yahoo Finance
The 5 Best Biotech ETFs of 2024 - etf.com
11 Best Biotech ETFs To Buy - Yahoo Finance
Tema ETFs: A Better Way to Invest in Life Sciences - StreetInsider
Tema Launches Third Medical-Themed ETF - FA Mag
New ETF Focuses On Obesity, Cardiovascular Disease Treatments - FA Mag
Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund - Reuters
12 Best Healthcare ETFs To Buy - Yahoo Finance
Investing in Oncology: A Biotech Revolution in Research, Diagnosis, and Treatment of Cancer - Nasdaq
Inside Tema ETFs' New Oncology ETF (CANC) - Nasdaq
Royalties and cancer treatments: Thematic ETFs take new directions - InvestmentNews
Tema Launches Two Innovative, Active ETF Thematic Strategies: Oncology & Global Royalties - Business Wire
Tema launches three innovative, professionally managed thematic ETFs: American Reshoring, Luxury, & Monopolies and Oligopolies - Business Wire
Getting in on global luxury - ETF Strategy
Biotechnology ETF List - ETFdb.com
Tema Oncology Etf Azioni (CANC) Dati Finanziari
Non sono disponibili dati finanziari per Tema Oncology Etf (CANC). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.51%
0.38%
Capitalizzazione:
|
Volume (24 ore):